English
Rossari Biotech Q2 Results
- BSE: 543213
- NSE: ROSSARI
- ISIN: INE02A801020
- Sector: Chemical Manufacturing
BSE
520.00
-14.65 (-2.74%)
-14.65 (-2.74%)Volume3.49 K
Updated: Mon 19 Jan, 2026 | 15:29:32
NSE
520.10-14.65 (-2.74%)
-14.65 (-2.74%)Volume75.40 K
Updated: Mon 19 Jan, 2026 | 15:25:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹586.11 Cr.(17.61%)
- Operating Profit₹53.69 Cr.(5.73%)
- Profit After Tax₹36.88 Cr.(4.37%)
- Operating Margin9.16%(-10.10%)
Note: Comparison is on YoY basis
Quarterly - Rossari Biotech Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 532.42 | 493.61 | 7.86% | 447.57 | 18.96% |
| Depreciation/ Amortization | 18.23 | 17.75 | 2.73% | 15.16 | 20.25% |
| Operating Income | 53.69 | 50.11 | 7.15% | 50.78 | 5.73% |
| Net Income | 36.88 | 33.60 | 9.76% | 35.33 | 4.37% |
| Other Operating Expenses Total | 75.53 | 67.05 | 12.65% | 59.14 | 27.70% |
| Net Income Before Taxes | 49.67 | 46.10 | 7.75% | 48.11 | 3.25% |
| Total Revenue | 586.11 | 543.72 | 7.80% | 498.35 | 17.61% |
| Selling/ General/ Admin Expenses Total | 37.80 | 37.46 | 0.89% | 32.56 | 16.08% |
| Diluted Normalized EPS | 6.66 | 6.06 | 9.90% | 6.38 | 4.39% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.